SELLAS Life Sciences Group Inc buy Wolf_of_WS
Start price
05.03.23
/
50%
€1.52
Target price
05.03.24
-
Performance (%)
-19.55%
End price
17.03.23
€1.22
Summary
This prediction ended on 17.03.23 with a price of €1.22. The prediction for SELLAS Life Sciences Group Inc disappointed with a performance of -19.55%. Wolf_of_WS has 50% into this predictionSELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| SELLAS Life Sciences Group Inc | -12.877% | -12.877% | 523.529% | 548.980% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by Wolf_of_WS for this prediction
In the thread SELLAS Life Sciences Group Inc diskutieren
Buy SELLAS Life Sciences Group Inc